[Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report].

Authors :: Maia HS
Turchetti R
Zajdenweber M
Brasil OF
Source :: Arquivos brasileiros de oftalmologia [Arq Bras Oftalmol] 2005 Jul-Aug; Vol. 68 (4), pp. 561-4. Date of Electronic Publication: 2005 Nov 22.
Publication Year :: 2005
Abstract: We report the use of photodynamic therapy with verteporfin for subfoveal choroidal neovacularization in central serous chorioretinopathy. Visual acuity improved (0.5 to 1.0) 30 days after the first session. After 141 days, the choroidal neovascularization reactivated and the patient was retreated. Again, visual acuity improved (0.5 to 1.0) 30 days afterwards. It remains stable after 20 months. Photodynamic therapy can be efficient in the treatment of choroidal neovascularization in central serous chorioretinopathy.

Subjects :: Choroidal Neovascularization etiology
Fluorescein Angiography
Humans
Male
Middle Aged
Retinal Detachment complications
Retinal Detachment drug therapy
Treatment Outcome
Verteporfin
Choroidal Neovascularization drug therapy
Fovea Centralis drug effects
Photochemotherapy
Photosensitizing Agents therapeutic use
Porphyrins therapeutic use

Full Text Access

Tools